GCS
CLPT icon

Gordian Capital (Singapore)’s ClearPoint Neuro CLPT Stock Holding History

Gordian Capital (Singapore)’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
+15,500
New +$194K 0.48% 39
2026
Q1 		– Sell
-3,000
Closed -$41K – 138
2025
Q4 		$41K Sell
3,000
-4,300
-59% -$79.7K 0.06% 87
2025
Q3 		$159K Buy
+7,300
New +$86K 0.22% 69

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Gordian Capital (Singapore)'s CLPT Position: Q2 2026 in Review

Gordian Capital (Singapore) opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 15,500 shares worth $277K. The stake represents 0.48% of the portfolio and ranks #39 among its holdings. This is a return to the name: Gordian Capital (Singapore) previously reported a position in CLPT as recently as Q4 2025.

Gordian Capital (Singapore) first reported a position in CLPT in Q3 2025 and has held it in 3 quarters since. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Gordian Capital (Singapore) held 15,500 shares of ClearPoint Neuro worth $277K as of Q2 2026.
  • ClearPoint Neuro was a new Gordian Capital (Singapore) position in Q2 2026.
  • ClearPoint Neuro made up 0.48% of Gordian Capital (Singapore)'s portfolio in Q2 2026, its #39 holding.
  • Gordian Capital (Singapore) first reported a position in ClearPoint Neuro in Q3 2025 and has held it in 3 quarters since.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.